best performing large cap stock between nov 2013 and mar 2015

Neurocrine Biosciences (NBIX) had the highest return between November 1, 2013 and March 31, 2015 by a large-cap US stock, returning 320.7%.

ASSET DATE % RETURN
Neurocrine Biosciences (NBIX)
11/1/2013 - 3/31/2015
320.66%
Skyworks Solutions (SWKS)
11/1/2013 - 3/31/2015
283.33%
Palo Alto Networks (PANW)
11/1/2013 - 3/31/2015
246.82%
Celsius (CELH)
11/1/2013 - 3/31/2015
237.96%
Broadcom (AVGO)
11/1/2013 - 3/31/2015
183.83%
Southwest Airlines (LUV)
11/1/2013 - 3/31/2015
159.49%
Centene (CNC)
11/1/2013 - 3/31/2015
152.64%
Monster Beverage (MNST)
11/1/2013 - 3/31/2015
140.48%
Super Micro Computer (SMCI)
11/1/2013 - 3/31/2015
139.61%
NXP Semiconductors (NXPI)
11/1/2013 - 3/31/2015
138.9%
Incyte (INCY)
11/1/2013 - 3/31/2015
134.78%
XPO Logistics (XPO)
11/1/2013 - 3/31/2015
124.54%
Electronic Arts (EA)
11/1/2013 - 3/31/2015
124.14%
CyberArk Software (CYBR)
11/1/2013 - 3/31/2015
122.28%
Burlington Stores (BURL)
11/1/2013 - 3/31/2015
120.65%
Edwards Lifesciences (EW)
11/1/2013 - 3/31/2015
117.69%
DexCom (DXCM)
11/1/2013 - 3/31/2015
117.59%
AerCap (AER)
11/1/2013 - 3/31/2015
115.02%
Stellantis (STLA)
11/1/2013 - 3/31/2015
114.61%
Molina Healthcare (MOH)
11/1/2013 - 3/31/2015
113.08%
MPLX (MPLX)
11/1/2013 - 3/31/2015
102.24%
Royal Caribbean Cruises (RCL)
11/1/2013 - 3/31/2015
99.83%
Illumina (ILMN)
11/1/2013 - 3/31/2015
98.59%
United Airlines (UAL)
11/1/2013 - 3/31/2015
98.09%
Biomarin Pharmaceutical (BMRN)
11/1/2013 - 3/31/2015
97.31%
Large-cap stocks are treated as having a market cap of $10B+.